Differential Bio Inc.

Differential Bio is a biotechnology company focused on bioprocess optimization, utilizing robotic lab automation and AI-driven insights to enhance fermentation processes for its clients. Differential Bio Inc. specializes in bioprocess optimization through an innovative platform that incorporates robotic lab automation and AI-driven insights. The company is headquartered in Munich, Germany.

Founded by a team with prior experience in biotech ventures, it has engaged in 1 deal as of March 26, 2025, raising EUR 2 million in funding. The funding round was co-led by Ananda Impact Ventures and ReGen Ventures, with contributions from Carbon13, Climate Capital Syndicate, Better Ventures, CDTM, and the University of Munich. Differential Bio specializes in bioprocess optimization through an innovative platform that leverages robotic lab automation and AI-driven insights. Their core offerings include a virtual scale-up platform that allows researchers to simulate fermentation processes, optimize bioprocess parameters, and conduct unlimited virtual experiments.

By mimicking large-scale stress factors in a microliter-scale environment, the company helps customers optimize microbial growth and fermentation outcomes before scaling to large-scale production. Their target customer base includes biotechnology firms engaged in microbial fermentation across North America, Europe, and Asia-Pacific. Differential Bio's revenue model is structured around subscription-based access to their web-based platform and associated services, allowing clients to run experimental simulations and optimize bioprocesses efficiently. Transactions typically occur between Differential Bio and biotechnology firms that seek to enhance their production capabilities through data-driven insights.

The platform's pricing structure accommodates diverse clientele, from small biotech startups to larger enterprises. Flagship services include AI-driven predictive modeling tools, streamlining the R&D process for customers, resulting in faster development cycles and cost-effective biomanufacturing solutions. In March 2025, Differential Bio Inc. raised EUR 2 million in Pre-Seed funding, which will be utilized to enhance its operations and technology, expand the team, and strengthen client partnerships.

The company is focused on developing new products aimed at improving bioprocess optimization and plans to expand into additional markets within Europe and Asia by the end of 2026.